 G Protein-coupled receptors
|
|
Ion channels
|
|
Nuclear receptors
|
|
 Protein kinases
|
Serine/threonine kinases
|
Receptor serine/threonine kinases (RSTK)
|
Receptor tyrosine kinases (RTK)
|
EGFR family
|
EGFR [HSA:1956] [KO:K04361]
|
 D07907 Erlotinib (INN)
D09724 Afatinib (USAN/INN)
D10858 Rociletinib (USAN/INN)
D10859 Olmutinib (USAN/INN)
D11115 Olmutinib hydrochloride (USAN)
D09883 Dacomitinib (INN)
D11251 Icotinib
D12001 Mobocertinib (USAN/INN)
D08108 Lapatinib (INN)
D04024 Lapatinib ditosylate (USAN) <JP/US>
D08950 Neratinib (USAN/INN)
D10898 Neratinib maleate <US>
D06407 Vandetanib (JAN/USAN/INN) <JP/US>
D03455 Cetuximab (USAN/INN) <JP/US>
D05350 Panitumumab (USAN/INN) <JP/US>
D10018 Necitumumab (USAN/INN) <JP/US>
D11894 Amivantamab (USAN/INN) <US>
D04862 Masoprocol (USAN/INN)
D03350 Canertinib dihydrochloride (USAN)
D05399 Pelitinib (USAN/INN)
D09660 Rindopepimut (USAN)
D09689 Varlitinib (USAN/INN)
D09690 Varlitinib tosylate (USAN)
D10031 Zalutumumab (USAN/INN)
D10439 Imgatuzumab (USAN/INN)
D10886 Naquotinib mesylate (USAN)
D10958 Naquotinib (USAN/INN)
D11125 Modotuximab (USAN/INN)
D11368 Mavelertinib (USAN/INN)
D11410 Lifirafenib (USAN/INN)
D11411 Lifirafenib maleate (USAN)
D11430 Nazartinib (USAN/INN)
D11434 Nazartinib mesylate (USAN)
D11750 Duligotuzumab (USAN)
D11772 Tesevatinib (USAN/INN)
D11773 Tesevatinib tosylate (USAN)
D11803 Cetuximab sarotalocan (USAN/INN)
D11805 Cetuximab sarotalocan sodium (genetical recombination) (JAN) <JP>
D11872 Serclutamab (USAN/INN)
D11874 Serclutamab talirine (USAN/INN)
D12229 Poziotinib (USAN/INN)
D12230 Poziotinib hydrochloride (USAN)
D12416 Petosemtamab (USAN/INN)
D12457 Tuxobertinib (USAN/INN)
D12709 Dalmitamig (USAN)
D12768 Ficerafusp alfa (USAN)
D12809 Bafisontamab (USAN/INN)
|
EGFR* [HSA_VAR:1956v2] [HSA:1956] [KO:K04361]
|
ERBB2 (HER2, CD340) [HSA:2064] [KO:K05083]
|
D09724 Afatinib (USAN/INN)
D09733 Afatinib dimaleate (USAN) <JP/US>
D09883 Dacomitinib (INN)
D10514 Dacomitinib (USAN) <JP/US>
D08108 Lapatinib (INN)
D08950 Neratinib (USAN/INN)
D11375 Trastuzumab duocarmazine (USAN/INN)
D03350 Canertinib dihydrochloride (USAN)
D04025 Mubritinib (USAN/INN)
D06610 Lapuleucel-T (USAN)
D09689 Varlitinib (USAN/INN)
D09690 Varlitinib tosylate (USAN)
D10344 Nelipepimut-S (USAN)
D11772 Tesevatinib (USAN/INN)
D11773 Tesevatinib tosylate (USAN)
D11991 Zenocutuzumab (USAN/INN)
D12011 Zanidatamab (USAN/INN)
D12229 Poziotinib (USAN/INN)
D12230 Poziotinib hydrochloride (USAN)
D12236 Runimotamab (USAN/INN)
D12457 Tuxobertinib (USAN/INN)
D12583 Anvatabart opadotin (USAN/INN)
D12584 Anvatabart pactil (USAN/INN)
D12879 Zongertinib (USAN/INN)
|
ERBB2* (HER2, CD340) [HSA_VAR:2064v1] [HSA:2064] [KO:K05083]
|
ERBB2* (HER2, CD340) [HSA_VAR:2064v1 2064v3] [HSA:2064] [KO:K05083]
|
ERBB3 (HER3) [HSA:2065] [KO:K05084]
|
ERBB4 (HER4) [HSA:2066] [KO:K05085]
|
D09724 Afatinib (USAN/INN)
D09733 Afatinib dimaleate (USAN) <JP/US>
D09883 Dacomitinib (INN)
D10514 Dacomitinib (USAN) <JP/US>
D08950 Neratinib (USAN/INN)
D10898 Neratinib maleate <US>
D03350 Canertinib dihydrochloride (USAN)
D09689 Varlitinib (USAN/INN)
D09690 Varlitinib tosylate (USAN)
|
INSR family
|
PDGFR family
|
FGFR family
|
VEGFR family
|
MET family
|
TRK family
|
EPH family
|
AXL family
|
ALK family
|
TIE family
|
ROR family
|
RET family
|
CCK family
|
Non-receptor tyrosine kinases
|
|
Cytokines and receptors
|
|
Cell surface molecules and ligands
|
|
Transporters
|
|
Enzymes
|
|
Nucleic acids
|
|
Not elsewhere classified
|
Target-based Classification of Drugs